|Articles|September 12, 2016

Takeda Partners With PRA Health Sciences

Takeda Pharmaceuticals has entered into a partnership agreement with PRA Health Sciences.

Takeda Pharmaceuticals has entered into a partnership agreement with PRA Health Sciences. Under this agreement PRA will manage Takeda’s pipeline and marketed products, clinical development and post-approval needs.

Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Articles

Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
Trial Data Leads to NCCN Recommendation for Modeyso in Recurrent High Grade Glioma Patients
September 12th 2025
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
September 11th 2025
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025

Trending on Applied Clinical Trials Online

Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients

Q&A: Strategies for Successful Global Clinical Trial Delivery

Trial Data Leads to NCCN Recommendation for Modeyso in Recurrent High Grade Glioma Patients

Latest NIMBLE Study Results Highlight Progress in gMG Research

© 2025 MJH Life Sciences^®

All rights reserved.